Subscribe To
Cidara therapeutics provides corporate update and reports first quarter 2023 financial results
SAN DIEGO, May 11, 2023 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology company developing long-acting therapeutics des...
May 11, 2023, 8:37 pm
Harpoon therapeutics reports first quarter 2023 financial results and provides corporate update
Enrollment for HPN217 (BCMA) and HPN328 (DLL3) remain on track, with data updates and selection of recommended Phase 2 doses for both ongoing clinical...
May 11, 2023, 8:30 pm
Theriva biologics reports first quarter 2023 operational highlights and financial results
– Continued to enroll patients in VIRAGE, the Phase 2b clinical trial of systemically administered VCN-01 in combination with chemotherapy for Pancr...
May 11, 2023, 12:00 pm
Oncocyte reports first quarter 2023 financial results
Nearing Manufacturing Start Up of First Kitted Product IRVINE, Calif., May 11, 2023 (GLOBE NEWSWIRE) — Oncocyte Corporation (Nasdaq: OCX), a precisi...
May 11, 2023, 12:00 pm
Dyne therapeutics reports first quarter 2023 financial results and business highlights
– On Track to Report Initial Data from ACHIEVE Clinical Trial of DYNE-101 in DM1 and DELIVER Clinical Trial of DYNE-251 in DMD During the Second Hal...
May 11, 2023, 11:30 am
Hookipa pharma reports first quarter 2023 financial results and recent business highlights
HOOKIPA on track to report Phase 2 data on HB-200 for head and neck cancer in combination with pembrolizumab in 2Q 2023 Phase 1 clinical trials initia...
May 11, 2023, 11:01 am
Applied therapeutics reports first quarter 2023 financial results
Demonstrated Long-term Clinical Benefit of Govorestat in ACTION-Galactosemia Kids Trial Strengthened Balance Sheet with $30 Million Private Placement ...
May 11, 2023, 11:00 am
Passage bio reports first quarter 2023 financial results and provides recent business highlights
On track to report interim clinical data for two lead programs, PBGM01 for GM1 gangliosidosis and PBFT02 for frontotemporal dementia (FTD), in 2023 Su...
May 11, 2023, 11:00 am
Optinose reports first quarter 2023 financial results and operational updates
Strong progress towards strategic objectives including acceptance of sNDA for review and prioritization of potential launch of XHANCE as first drug ap...
May 11, 2023, 11:00 am
Tcr² therapeutics reports first quarter 2023 financial results and provides corporate update
CAMBRIDGE, Mass., May 11, 2023 (GLOBE NEWSWIRE) — TCR2 Therapeutics Inc. (Nasdaq: TCRR) (TCR2 or the Company), a clinical-stage cell therapy company...
May 11, 2023, 10:30 am
Epsilon reports first quarter 2023 results
HOUSTON, May 10, 2023 (GLOBE NEWSWIRE) — Epsilon Energy Ltd. (“Epsilon” or the “Company”) (NASDAQ: EPSN) today reported first quarter 2023 f...
May 11, 2023, 3:03 am
Porch group reports first quarter 2023 results
$87 Million Revenue, With Growth Of 37% Year-Over-Year.Adjusted EBITDA In Line With Expectations.Insurance Carrier Top Decile 2022 Combined Loss Ratio...
May 10, 2023, 9:52 pm
Htg molecular diagnostics reports first quarter 2023 results and provides recent business highlights
TUCSON, Ariz., May 10, 2023 (GLOBE NEWSWIRE) — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a platform-based life science tools and drug di...
May 10, 2023, 9:51 pm
Riot platforms reports first quarter 2023 financial results, current operational and financial highlights
Riot Reports $73.2 Million in Total Revenue, and New All-Time Records in 2,115 Bitcoin Produced and Hash Rate Capacity of 10.5 EH/s CASTLE ROCK, Colo....
May 10, 2023, 9:15 pm
Tenaya therapeutics reports first quarter 2023 financial results and provides business update
TN-201 Received Fast Track Designation from the FDA Dosing Complete in Phase 1 Clinical Trial of TN-301; Data Expected in Second Half 2023 Renowned Re...
May 10, 2023, 8:19 pm
Tempest reports first quarter 2023 financial results and provides business update
BRISBANE, Calif., May 10, 2023 (GLOBE NEWSWIRE) — Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage oncology company developing first-in-c...
May 10, 2023, 8:15 pm
Vishay intertechnology reports first quarter 2023 results
MALVERN, Pa., May 10, 2023 (GLOBE NEWSWIRE) — Vishay Intertechnology, Inc., (NYSE: VSH), one of the world’s largest manufacturers of discrete semi...
May 10, 2023, 11:05 am
Xometry reports first quarter 2023 results
Q1 revenue increased 26% year-over-year driven by stronger-than-expected marketplace growth of 35% year-over-year. Marketplace revenue up 10% quarter-...
May 10, 2023, 11:02 am
Iteos reports first quarter 2023 financial results and provides business updates
– Belrestotug, formerly EOS-448, is advancing through multiple late-stage clinical trials including both doublet and triplet regimens – First-in-c...
May 10, 2023, 11:01 am
Alaunos therapeutics reports first quarter 2023 financial results
Actively enrolling patients and manufacturing cryopreserved products for TCR-T Library Phase 1/2 trial; expect to report interim data in the third qua...
May 10, 2023, 11:00 am